This article directly stems from the research process for our global venture capital investors database. Based on this list and our advanced keyword crawler technology, we created a list of venture capital investors that mention immunology-related keywords on their website. The list – offered as an Excel file – is perfectly suited to get in touch with the most relevant investors in the field.
This article highlights three significant immunology venture capital investment funds in Oceania from our keyword crawler generated immunology venture capital funds list.
1. GBS Venture Partners (Australia)
GBS was founded in 1996 and is a venture capital firm that invests in young businesses and products. They are especially interested in healthcare, biotechnology, and life science start-ups. Portfolio companies include Moximed, AirXpanders, and Hatchtech.
2. Matu (New Zealand)
The company’s name stems from the Te Reo Maori and means substance or scientific matter. This also describes the essence of the company that focuses on investing in science and technology start-ups. A portfolio company in the pharma industry is Ferronova, a nanoparticle technology that traces and visualizes the pathways in which cancer spreads to the lymph nodes.
3. One Ventures (Australia)
With over $650 million in funds under management, One Ventures is one of Australia’s leading VC firms. They invest and also support early-stage businesses to grow and expand. A company One Ventures has funded is Clinical Genomics, who develop specific blood tests for cancer detection.
Picture Source: Myriam Zilles